NeuroStim TMS

NeuroStim TMS is a leading national provider of Transcranial Magnetic Stimulation (TMS) therapy, specializing in non-invasive, drug-free treatments for mental health disorders. Founded in 2017 and headquartered in Seattle, the company operates a network of over 16 clinics across Washington, Arizona, and Minnesota. NeuroStim is recognized for its clinical innovation, having pioneered the ONE-D (Optimized, Neuroplasticity-Enhanced Depression Treatment) protocol, which condenses a full course of TMS therapy into a single day. The company's services target treatment-resistant depression, OCD, PTSD, and anxiety, achieving patient response and remission rates that significantly exceed national averages. Led by CEO Walt Guidice and a team of renowned medical experts, NeuroStim TMS has administered over 250,000 treatments to date.